Discovery of SARS-CoV-2-E channel inhibitors as antiviral candidates
Yi Wang(Chinese Academy of Sciences), Bingqing Xia(Shanghai Institute of Materia Medica)
Cited by 30
Related Papers
SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target
|Cell Research|2021|197
A Role for Complement in Antibody-Mediated Inflammation: C5-Deficient DBA/1 Mice Are Resistant to Collagen-Induced Arthritis
|The Journal of Immunology|2000|193
Extracellular vesicles mediate antibody-resistant transmission of SARS-CoV-2
|Cell Discovery|2023|65